Lunchtime Seminars
LS-1 Lung hyperinflation and comorbidities in COPD
LS-2 Efficacy of respiratory quinolones against community-acquired pneumonia
LS-3 Diagnosis and management of PAH
LS-4 Early intervention in bronchial asthma
LS-5 Chemotherapy for outpatients with lung cancer in Japan
LS-6 A new concept of β2-agonist therapy in asthma and COPD
LS-7 Unmet needs in asthma: filling the gap
LS-8 Sleep in COPD and the role of noninvasive ventilation
LS-9 Evaluation of clarithromycin (CAM) in the management of patients with pulmonary Mycobacterium Avium Complex (MAC)
LS-10 Science of lung auscultation
LS-11 Reassessment of theophylline: its role in asthma management
LS-12 Roles of long-acting bronchodilators in COPD
LS-13 Current status of EGFR-TKI for NSCLC
LS-1 Lung Hyperinflation and Comorbidities in COPD
Time | 12:40‑13:30 Monday 20 November |
Venue | Main Hall (seating capacity: 1,840) |
Chair | Masaharu Nishimura |
Speaker | Leonardo M. Fabbri |
This seminar is sponsored by Nippon Boehringer Ingelheim Co., Ltd and Pfizer Japan Inc.
(See also COPD Educational Event 2005)
Top
LS-2 Efficacy of Respiratory Quinolones against Community-Acquired Pneumonia
Time | 12:40‑13:30 Monday 20 November |
Venue | Room B‑1 (seating capacity: 210) |
Chair | Mitsuo Kaku |
Speaker | Yoshihito Niki |
This seminar is sponsored by Shionogi & Co., Ltd
Top
LS-3 Diagnosis and Management of PAH
Time | 12:40‑13:30 Monday 20 November |
Venue | Room B‑2 (seating capacity: 210) |
Chair | Hiroshi Kimura |
Speaker | Lewis J. Rubin |
This seminar is sponsored by Actelion Pharmaceuticals Ltd.
Top
LS-4 Early Intervention in Bronchial Asthma
Time | 12:40‑13:30 Monday 20 November |
Venue | Room C‑1 (seating capacity: 100) |
Chair | Yuji Tohda |
Speaker | Shigemi Yoshihara |
This seminar is sponsored by Astellas Pharma Inc.
Top
LS-5 Chemotherapy for Outpatients with Lung Cancer in Japan
Time | 12:40‑13:30 Monday 20 November |
Venue | Room C‑2 (seating capacity: 100) |
Chair | Fumio Imamura |
Speaker | Koji Takeda |
This seminar is sponsored by Bristol-Myers Squibb Company
Top
LS-6 A New Concept of β2-agonist Therapy in Asthma and COPD
Time | 12:40‑13:30 Monday 20 November |
Venue | Room D (seating capacity: 250) |
Chair | Kazuo Akiyama |
Speaker | Hiroaki Kume |
This seminar is sponsored by Otsuka Pharmaceutical Co., Ltd.
(See also COPD Educational Event 2005)
Top
LS-7 Unmet Needs in Asthma: Filling the Gap
Time | 12:40‑13:30 Tuesday 21 November |
Venue | Room A (seating capacity: 550) |
Chair | Ken Ohta |
Speaker | Carlos E. Baena-Cagnani |
This seminar is sponsored by Teijin Pharma Limited and Altana Pharma
Top
LS-8 Sleep in COPD and the role of noninvasive ventilation
Time | 12:40‑13:30 Tuesday 21 November |
Venue | Room B‑1 (seating capacity: 210) |
Chair | Motoharu Oi |
Speaker | Nicholas S. Hill |
This seminar is sponsored by Fuji Respironics Co., Ltd.
(See also COPD Educational Event 2005)
Top
LS-9 Evaluation of Clarithromycin (CAM) in the Management of Patients with Pulmonary Mycobacterium Avium Complex (MAC)
Time | 12:40‑13:30 Tuesday 21 November |
Venue | Room B‑2 (seating capacity: 160) |
Chair | Jiro Fujita |
Speaker | Naoki Hasegawa |
This seminar is sponsored by Taisho Toyama Pharmaceutical Co., Ltd
Top
LS-10 Science of Lung Auscultation
Time | 12:40‑13:30 Tuesday 21 November |
Venue | Room C‑1 (seating capacity: 100) |
Chair | Yongyudh Ploysongsang |
Speaker | Hans Pasterkamp |
This seminar is sponsored by Eisai Co., Ltd.
Top
LS-11 Reassessment of Theophylline: Its Role in Asthma Management
Time | 12:40‑13:30 Tuesday 21 November |
Venue | Room C‑2 (seating capacity: 100) |
Chair | Sohei Makino |
Speaker | Makoto Nagata |
This seminar is sponsored by Mitsubishi Pharma Corporation
Top
LS-12 Roles of Long-acting Bronchodilators in COPD
Time | 12:40‑13:30 Tuesday 21 November |
Venue | Room D (seating capacity: 250) |
Chair | Michiaki Mishima |
Speaker | Kazuto Hirata |
This seminar is sponsored by Maruho Co., Ltd. and Abbott Japan Co., Ltd.
(See also COPD Educational Event 2005)
Top
LS-13 Current Status of EGFR-TKI for NSCLC
Time | 12:40‑13:30 Tuesday 21 November |
Venue | Room E (seating capacity: 250) |
Chair | Ichiro Kawase |
Speaker | Seiji Yano |
This seminar is sponsored by AstraZeneca K.K.
Top
(Note: These are not public sessions. Attendance is reserved for those who have
registered for the APSR2006 Congress.)
|